403 related articles for article (PubMed ID: 31295542)
1. Enzyme responsive drug delivery systems in cancer treatment.
Shahriari M; Zahiri M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
J Control Release; 2019 Aug; 308():172-189. PubMed ID: 31295542
[TBL] [Abstract][Full Text] [Related]
2. Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment.
Zhang ZT; Huang-Fu MY; Xu WH; Han M
Eur J Pharm Biopharm; 2019 Apr; 137():122-130. PubMed ID: 30776412
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
Li L; Yang WW; Xu DG
J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
[TBL] [Abstract][Full Text] [Related]
4. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
Saravanakumar K; Hu X; Ali DM; Wang MH
Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
[TBL] [Abstract][Full Text] [Related]
5. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
6. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
[TBL] [Abstract][Full Text] [Related]
7. Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy.
Vaghasiya K; Ray E; Singh R; Jadhav K; Sharma A; Khan R; Katare OP; Verma RK
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():112027. PubMed ID: 33812642
[TBL] [Abstract][Full Text] [Related]
8. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy.
Wu F; Qiu F; Wai-Keong SA; Diao Y
Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
Andresen TL; Thompson DH; Kaasgaard T
Mol Membr Biol; 2010 Oct; 27(7):353-63. PubMed ID: 20939771
[TBL] [Abstract][Full Text] [Related]
10. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
Alshememry AK; El-Tokhy SS; Unsworth LD
Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.
Kapalatiya H; Madav Y; Tambe VS; Wairkar S
Drug Deliv Transl Res; 2022 Jun; 12(6):1293-1305. PubMed ID: 34251612
[TBL] [Abstract][Full Text] [Related]
12. Advances in intelligent-responsive nanocarriers for cancer therapy.
Tian M; Xin X; Wu R; Guan W; Zhou W
Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-based ATP-responsive delivery systems for cancer diagnosis and treatment.
Sameiyan E; Bagheri E; Dehghani S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Acta Biomater; 2021 Mar; 123():110-122. PubMed ID: 33453405
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
[TBL] [Abstract][Full Text] [Related]
15. Smart Drug Delivery Systems in Cancer Therapy.
Unsoy G; Gunduz U
Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
[TBL] [Abstract][Full Text] [Related]
16. Stimuli-responsive Carriers for Controlled Intracellular Drug Release.
Sheng Y; Hu J; Shi J; Lee LJ
Curr Med Chem; 2019; 26(13):2377-2388. PubMed ID: 28875840
[TBL] [Abstract][Full Text] [Related]
17. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
18. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
[TBL] [Abstract][Full Text] [Related]
19. [Progress in dual-responsive nanocarriers based on acid sensitivity for anticancer drug].
Lu X; Guo X; Wan D; Pan J
Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1723-1731. PubMed ID: 33164451
[TBL] [Abstract][Full Text] [Related]
20. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments.
Sun T; Jiang C
Adv Drug Deliv Rev; 2023 May; 196():114773. PubMed ID: 36906230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
